000 | 01336 a2200349 4500 | ||
---|---|---|---|
005 | 20250513074941.0 | ||
264 | 0 | _c19930827 | |
008 | 199308s 0 0 eng d | ||
022 | _a0026-895X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCarfagna, M A | |
245 | 0 | 0 |
_aInteraction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity. _h[electronic resource] |
260 |
_bMolecular pharmacology _cJul 1993 |
||
300 |
_a129-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xpharmacology |
650 | 0 | 4 |
_aChlorpromazine _xpharmacology |
650 | 0 | 4 |
_aDiphenhydramine _xpharmacology |
650 | 0 | 4 | _aFluorescence Polarization |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aPropylamines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aSynaptic Membranes _xdrug effects |
700 | 1 | _aMuhoberac, B B | |
773 | 0 |
_tMolecular pharmacology _gvol. 44 _gno. 1 _gp. 129-41 |
|
999 |
_c8392790 _d8392790 |